551 results on '"Conran, Nicola"'
Search Results
2. Molecular and cellular effects of in vivo chronic intravascular hemolysis and anti-inflammatory therapeutic approaches
3. Heme induces significant neutrophil adhesion in vitro via an NFκB and reactive oxygen species-dependent pathway
4. Introduction to the thematic issue on infectious diseases: Highlights of the Brazilian virology conference 2022 and International Experimental Biology and Medicine Conference (IEBMC), Brazil 2022
5. Inflammation and Sickle Cell Anemia
6. CXCR4hi effector neutrophils in sickle cell anemia: potential role for elevated circulating serotonin (5-HT) in CXCR4hi neutrophil polarization
7. S266: DIFFERENT MOLECULAR VASO-OCCLUSIVE TRIGGERS STIMULATE DISTINCT VASO-OCCLUSIVE PROFILES: IN VIVO RESULTS FROM MICE WITH SICKLE CELL ANEMIA
8. Role of Macrophages in Sickle Cell Disease Erythrophagocytosis and Erythropoiesis
9. Acute hemolytic vascular inflammatory processes are prevented by nitric oxide replacement or a single dose of hydroxyurea
10. In vitro microfluidic model for the study of vaso-occlusive processes
11. Introduction to the thematic issue: Recognition of women leaders in Science
12. Reduced plasma angiotensin II levels are reversed by hydroxyurea treatment in mice with sickle cell disease
13. In vitro and in vivo anti-angiogenic effects of hydroxyurea
14. Increased adhesive properties of neutrophils and inflammatory markers in venous thromboembolism patients with residual vein occlusion and high D-dimer levels
15. Red cell DAMPs and inflammation
16. P-Selectin Blockage Potentiates the Inhibiting Effects of Inflammasome Cytokine Neutralization on Leukocyte Recruitment in an In Vivo Model of Acute Sickle Cell Vaso-Occlusion
17. Altered red cell and platelet adhesion in hemolytic diseases: Hereditary spherocytosis, paroxysmal nocturnal hemoglobinuria and sickle cell disease
18. Increased adhesive and inflammatory properties in blood outgrowth endothelial cells from sickle cell anemia patients
19. Association of plasma CD40L with acute chest syndrome in sickle cell anemia
20. Piezo1 activation augments sickling propensity and the adhesive properties of sickle red blood cells in a calcium‐dependent manner.
21. Hydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease mice
22. Safe use of hydroxycarbamide in sickle cell disease patients hospitalized for painful vaso‐occlusive episodes during the randomized, open‐label HELPS study
23. Role of the Mac-1 and VLA-4 integrins, and concomitant Th2-cytokine production, in nitric oxide modulated eosinophil migration from bone marrow to lungs in allergic mice
24. Pain mechanisms in sickle cell disease. Are we closer to a breakthrough?
25. TGF-β1 Reduces Neutrophil Adhesion and Prevents Acute Vaso-Occlusive Processes in Sickle Cell Disease Mice
26. Reduced rate of sickle-related complications in Brazilian patients carrying HbF-promoting alleles at the BCL11A and HMIP-2 loci
27. Reduced blood pressure in sickle cell disease is associated with decreased angiotensin converting enzyme (ACE) activity and is not modulated by ACE inhibition
28. Editorial: Inflammatory Mechanisms of Hemolytic Diseases
29. Sickle Cell Disease and Oxidative Stress: Implications for a Role of Diminished Endothelial SOD2 in Pulmonary Complications
30. Accelerated low‐density neutrophil transition in sickle cell anaemia may contribute to disease pathophysiology
31. Hemoglobin disorders and endothelial cell interactions
32. Neutralization of Inflammasome-Processed Cytokines Reduces Inflammatory Mechanisms and Leukocyte Recruitment in the Vasculature of TNF-α-Stimulated Sickle Cell Disease Mice
33. Simvastatin abrogates inflamed neutrophil adhesive properties, in association with the inhibition of Mac-1 integrin expression and modulation of Rho kinase activity
34. Inhibition of phosphodiesterase 9A reduces cytokine-stimulated in vitro adhesion of neutrophils from sickle cell anemia individuals
35. Intravascular Hemolysis: A Disease Mechanism Not to Be Ignored
36. Didox (3,4-dihydroxybenzohydroxamic acid) reduces the vascular inflammation induced by acute intravascular hemolysis
37. Leukocyte numbers correlate with plasma levels of granulocyte–macrophage colony-stimulating factor in sickle cell disease
38. Neutralization of IL-1β and P-Selectin Inhibition Attenuate Organ Injury in Mice with Sickle Cell Disease
39. Unravelling the Mechanism behind Ineffective Erythropoiesis in Sickle Cell Disease: The Role of GATA-1
40. Caspase-1 As a Therapeutic Target in Intravascular Hemolysis-Induced Microvascular Inflammation and Occlusive Processes
41. Sickle cell vaso-occlusion: The dialectic between red cells and white cells
42. Vasculopathy in Sickle Cell Disease: From Red Blood Cell Sickling to Vascular Dysfunction
43. Hydroxycarbamide reduces eosinophil adhesion and degranulation in sickle cell anaemia patients
44. Elevated plasma levels and platelet-associated expression of the pro-thrombotic and pro-inflammatory protein, TNFSF14 (LIGHT), in sickle cell disease
45. COVID-19: Time for precision epidemiology
46. Increased adhesive properties of platelets in sickle cell disease: roles for αIIbβ3-mediated ligand binding, diminished cAMP signalling and increased phosphodiesterase 3A activity
47. Accelerated low‐density neutrophil transition in sickle cell anaemia may contribute to disease pathophysiology.
48. High expression of the cGMP-specific phosphodiesterase, PDE9A, in sickle cell disease (SCD) and the effects of its inhibition in erythroid cells and SCD neutrophils
49. Role for cAMP-protein kinase A signalling in augmented neutrophil adhesion and chemotaxis in sickle cell disease
50. Inhibition of caspase-dependent spontaneous apoptosis via a cAMP-protein kinase A dependent pathway in neutrophils from sickle cell disease patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.